Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia

To investigate the efficacy of eltrombopag for the treatment of thrombocytopenia in patients with chronic hepatitis C, a phase II, single-arm, open-label study with a 9-week pre-antiviral phase was conducted, followed by a 48-week antiviral phase and a 24-week follow-up phase. The proportion of pati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Ther Med
Main Authors: Kawaguchi, Takumi, Komori, Atsumasa, Fujisaki, Kunio, Nishiguchi, Shuhei, Kato, Michio, Takagi, Hitoshi, Tanaka, Yasuhito, Notsumata, Kazuo, Mita, Eiji, Nomura, Hideyuki, Shibatoge, Mitsushige, Takaguchi, Koichi, Hattori, Toshihiro, Sata, Michio, Koike, Kazuhiko
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6566053/
https://ncbi.nlm.nih.gov/pubmed/31258695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2019.7616
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados